Catalyst Capital Advisors’s CVS Health CVS Stock Holding History

Catalyst Capital Advisors’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-2,800	Closed	-$183K	–	405
2018 Q4	$183K	Hold	2,800	–	–	0.01%	229
2018 Q3	$220K	Buy	2,800 +2,300	+460%	+$164K	0.01%	238
2018 Q2	$32K	Sell	500 -2,100	-81%	-$138K	﹤0.01%	305
2018 Q1	$162K	Sell	2,600 -34,634	-93%	-$2.48M	0.01%	261
2017 Q4	$2.7M	Sell	37,234 -5,919	-14%	-$430K	0.1%	111
2017 Q3	$3.51M	Sell	43,153 -8,263	-16%	-$654K	0.15%	95
2017 Q2	$4.14M	Sell	51,416 -438	-0.8%	-$34.6K	0.18%	89
2017 Q1	$4.07M	Buy	51,854 +44,684	+623%	+$3.57M	0.2%	91
2016 Q4	$566K	Buy	7,170 +3,000	+72%	+$243K	0.04%	195
2016 Q3	$371K	Sell	4,170 -1,200	-22%	-$113K	0.04%	217
2016 Q2	$514K	Hold	5,370	–	–	0.1%	186
2016 Q1	$557K	Buy	+5,370	New	+$522K	0.09%	177
2015 Q1	–	Sell	-5,600	Closed	-$539K	–	463
2014 Q4	$539K	Buy	+5,600	New	+$493K	0.06%	219

Other funds holding CVS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Catalyst Capital Advisors's CVS Position: Q1 2019 in Review

Catalyst Capital Advisors sold out of CVS Health (CVS) in Q1 2019, closing a stake of 2,800 shares — an estimated $183K sold.

Catalyst Capital Advisors first reported a position in CVS in Q4 2014 and held it in 13 quarters. The position peaked at $4.14M in Q2 2017. 1,707 funds tracked by Wall St. Rank hold CVS as of Q1 2019.

Catalyst Capital Advisors reported no remaining CVS Health position as of Q1 2019 after selling out during the quarter.
Catalyst Capital Advisors sold 2,800 CVS Health shares in Q1 2019, an estimated $183K.
Catalyst Capital Advisors first reported a position in CVS Health in Q4 2014 and held it in 13 quarters.
Catalyst Capital Advisors's CVS Health position peaked at $4.14M in Q2 2017.
1,707 funds tracked by Wall St. Rank held CVS Health as of Q1 2019.

Based on Catalyst Capital Advisors's 13F filing for Q1 2019, filed 8 May 2019.